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Abstract
Background: Early morbidity and mortality are generally lower after endovascular aortic repair (EVAR), than after
open repair but re-interventions and late complications are more common. The aim of the present study was to
make a detailed description of re-interventions after EVAR-including incidence, indications, procedures, and
outcome-with special reference to non-access-related re-interventions.
Methods: This is a retrospective single-center cohort study of re-interventions after standard EVAR with special
reference to non-access-related re-interventions. Consecutive patients (n = 405) treated with standard EVAR for
non-ruptured (n = 337) or ruptured (n = 68) infrarenal aneurysms between 2005 and 2013 were analysed. Median
follow-up was 29 months (range 0–108).
Results: Eighty-nine patients (22 %) underwent 113 re-interventions during follow-up. Twenty-seven patients (7 %)
had 28 access related re-intervention, 65 patients (16 %) had 85 non-access related reinterventions. Non-access
related re-interventions were more common in ruptured aneurysms than in unruptured aneurysms (22 vs. 15 %,
p = 0.002). The most frequent indications were endoleak type I (n = 19), type II (n = 21), or type III (n = 5); stent graft
migration (n = 9); and thrombosis (n = 14). The most frequent procedures were embolization of endoleak type II
(n = 21), additional iliac stent graft (n = 19), proximal extension (n = 12), thrombolysis (n = 8), iliac limb bare-metal
stenting (n = 6), and stent graft relining (n = 7). Endovascular technique was used in 83 % of re-interventions.
Thirty-day mortality after non-access-related re-interventions was 15 % when initiated from symptoms (rupture or
infection) and 0 % when initiated from follow-up findings (p = 0.014). Cumulative survival five years after EVAR was
72 % in patients with a re-intervention and 59 % in patients without (p = 0.21).
Conclusions: Non-access-related re-intervention rates are still considerable after EVAR and more frequent after
ruptured aneurysms. Endoleak embolization is the most frequent procedure, followed by additional iliac stent grafts.
Outcomes after re-interventions are generally good, except when initiated by rupture or infection.
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Background
Endovascular aortic repair (EVAR) was first reported by
Volodos in 1988 [1] and by Parodi in 1991 [2]. During
the last decade, an increasing number of abdominal aor-
tic aneurysms (AAAs) and iliac aneurysms have been
treated with EVAR rather than with open repair. In the
Swedish National Registry (Swedvasc), 59 % of all aortic
repair procedures were performed with endovascular
techniques in 2013, as compared to 25 % ten years
earlier [3, 4]. EVAR has been compared with open repair
for the treatment of AAA in several randomized and
non-randomized studies. Early morbidity and mortality
are generally lower after EVAR, but re-interventions and
late complications appear to be more common [5–12],
although there have been contradictory reports [13].
While the results of the primary EVAR procedure are
well-described in the literature [5–7], there have been
few publications reporting the whole spectrum of re-
interventions after EVAR, including those related to the
arterial access. The aim of the present study was there-
fore to make a detailed description of re-interventions
after EVAR-including incidence, indications, procedures,




A consecutive series of patients treated with EVAR for
abdominal or iliac aneurysms at Sahlgrenska University
Hospital between 2005 and 2013 were retrospectively
reviewed. During the 9-year period, 405 patients (mean
age 75 ± 7 years, 84 % men) were treated for unruptured
(n = 337) or ruptured (n = 68) infrarenal aneurysms.
Aneurysm pathology was atherosclerotic in 379 cases,
inflammatory in 12 cases, mycotic in 13 cases and aortic
dissection with common iliac artery aneurysm in 1 case.
Median follow-up time was 29 months (range 0–108).
One patient was lost to follow up. This patient was a
foreign citizen treated for a ruptured AAA and dis-
charged at day 11 postoperatively. There were no re-
interventions or complications during hospital stay in
this patient. Patient characteristics are presented in
Table 1 and Fig. 1. The rate of endovascular treatment
of AAA at our institution was 28 % in 2005 and 56 % in
2013.
Study protocol
Patient records, institutional databases, and national
registry data were reviewed regarding primary repair,
complications, re-interventions, and survival. National
registry data were validated using the medical records.
Juxta- and suprarenal aneurysms treated with fenes-
trated, branched, or chimney stent grafts during the
period were excluded. Rupture of an aneurysm was
defined as retroperitoneal hematoma and/or extravasation
of contrast on preoperative computed tomography (CT).
A re-intervention was defined as any procedure (open
or endovascular) where the decision to re-intervene was
taken after the patient had left the operating theatre
after the EVAR procedure. Re-interventions were catego-
rized as either being access-related or not access-related.
Access-related re-interventions included suture of access
bleeds, distal thrombembolectomy, patch angioplasty, or
thromboendarterectomy of the common femoral artery.
Non-access-related re-interventions included all remaining
secondary procedures related to the primary EVAR. The
numbers and types of re-interventions were recorded, as
well as the timing in relation to the primary EVAR. The
follow-up program after EVAR consisted of CT investiga-
tions one and 12 months postoperatively, and annually
thereafter. Indications for treatment were: endoleak type I
and III was treated in the absence of contraindications and
endoleak type II was treated only when concurrent
aneurysm sac expansion > 5 mm was observed. Migration
without endoleak was treated if the proximal or distal
sealing zones became clearly shorter than specified in the
instructions for use for the respective stent graft. Early mor-
tality was defined as death within 30 days or in hospital.
Mortality data were collected from the Swedish Civil Regis-
try. Re-interventions were reported according to the stan-
dards for endovascular aortic aneurysm repair published by
the Society for Vascular Surgery [14].
Stent grafts
The following types of stent grafts were used: Endurant®
(Medtronic, Santa Rosa, CA, USA) (n = 237, 59 %), Zen-
ith Flex® (Cook Inc., Bloomington, IN, USA) (n = 86,
21 %), Excluder® (W. L. Gore, Flagstaff, AZ, USA) (n =
55, 14 %), Talent® (Medtronic) (n = 15, 4 %), Zenith LP®
(Cook Inc.) (n = 8, 2 %), and Ovation® (Trivascular, Santa
Rosa, CA, USA) (n = 2, 0.5 %). Fifteen Zenith iliac-
branched devices were used. Two patients were
converted to open surgery and therefore did not have a
stent graft in place at the end of surgery. In the first
patient access problems made it impossible to introduce
a stent graft, the second patient had a stent graft mis-
takenly covering coeliac trunk branches with low origins.
Statistical analysis
Continuous data are presented as mean and standard
deviation (for data with normal distribution) or median
and interquartile range (for data that were not normally
distributed). Normality of data was checked with the
Kolmogorov-Smirnov test. Categorical data are pre-
sented with numbers and percentage and they were
compared between groups with Fisher’s exact test. Cox
regression was used to identify independent predictors
for non-access-related re-interventions. Kaplan-Meier
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curves were used to analyze cumulative long-term sur-
vival, followed by log-rank test for group comparisons.
Any p-value < 0.05 was considered to be statistically
significant. All statistical calculations were performed
with SPSS 22 (IBM Corp., Armonk, NY, USA).
Results
General
Overall 30-day mortality after the primary EVAR pro-
cedure was 2.5 % (10/405) - 0.6 % (2/337) for unrup-
tured aneurysms and 12 % (8/68) for ruptured
aneurysms (p < 0.001). Early mortality in the non-
ruptured group was caused by a stent graft inadvertently
placed covering the renal arteries resulting in uremia in
one patient and lower extremity ischemia and multi
organ failure after conversion to open surgery in one pa-
tient. The mortality in the rupture group was in all cases
caused by complications related to massive bleeding and
multi organ failure. Five-year survival was 62 % in the
whole material, 64 % in unruptured aneurysms and 39 %
in ruptured aneurysms, respectively (p = 0.002).
Eighty-nine of the 405 patients (22 %) underwent 113
re-interventions during the follow-up period. Twenty-
eight re-intervention episodes in 27 patients (7 %) were
related to the arterial access in the groins. Eighty-five re-
intervention episodes in 65 patients (16 %) were not
access-related. Three patients underwent both access-
and non-access-related re-interventions. Median hospital
stay after a non-access-related re-intervention was two
days (range 0–46).
Access-related re-interventions
Twenty-eight access-related re-interventions were
recorded in our series. Most were done in the early post-
operative phase: 20/28 during the same hospital stay, 0–
2 days after EVAR. The prevalence of access-related re-
interventions was not significantly different for ruptured
and unruptured aneurysms: 8.8 % vs. 6.8 % (p = 0.60).
740 large access punctures were performed in 405 pa-
tients. Standard techniques for arterial closure was either
the percutaneous pre-suture technique using Prostar
XL® (Chicago, IL, USA) or fascia suture as described by
Larzon et al. [15]. Surgical cut down was used only in
selected patients with heavy calcifications in the com-
mon femoral artery. Re-interventions were performed in
13/438 (3 %) groins after closure with Prostar XL, 7/228
(3 %) after fascia suture, 6/42 (14 %) after cut down, and
in 2/16 cases (32 groins) (12 %) after femoro-femoral by-
pass, (p = 0.009 for cut down vs fascia suture and Prostar
XL). Indications for access-related re-interventions were
Table 1 Patients characteristics with comparison for groups with and without non-access related re-interventions after EVAR
All No re-interventions Re-interventions P value
n = 405 n = 340 n = 65
Age 74.8 (7.3)* 74.9 (7.4)* 74.2 (7.0)* 0.87
Male Gender 338 (83.5 %) 278 (81.8 %) 60 (92.3 %) 0.046
Body mass index 27.1 (5.2)* (n = 225) 27.1 (5.2)* (n = 195) 27.6 (4.8)* (n = 30) 0.76
Type of aneurysm
Atherosclerotic 379 (94 %) 319 (94 %) 59 (91 %) 0.51
Inflammatory 12 (3.0 %) 9 (2.6 %) 3 (4.6 %)2 0.27
Mycotic 13 (3.2 %) 11 (3.2 %) (3.1 %) 0.94
Other 1 (0.2 %) 1 (0.5 %) 1 (1.5 %) 0.28
Ruptured aneurysm 68 (16.8 %) 53 (15.6 %) 15 (23.1 %) 0.002
AAA diam (mm) 66 (13.0)* (n = 381) 65 (12.9)* (n = 322) 68 (13.2)* (n = 59) 0.026
CIA diam (mm) 45 (13.0)* (n = 49) 45 (13.8)* (n = 39) 47 (12.0)* (n = 10) 0.52
Serum creatinine (umol/L) 104 (66.7)* 103 (60)* 111 (94.3)* 0.082
Diabetes mellitus 69 (17.0 %) 60 (17.6 %) 9 (13.8 %) 0.65
Known pulmonary disease 89 (22.0 %) 77 (22.6 %) 12 (18.5 %) 0.68
Previous cardiac disease** 189 (46.7 %) 160 (47.1 %) 29 (44.6 %) 0.54
Dialysis 13 (3.2 %) 10 (3.0 %) 3 (4.6 %) 0.27
Previous cerebral infarction/TIA 51 (12.6 %) 46 (13.6 %) 5 (7.7 %) 0.22
Hypertension 295 (72.8 %) 253 (74.4 %) 42 (64.6 %) 0.33
Smoking (ever) 267/340 (78.5 %) 232/290 (80.0 %) 35/50 (70.0 %) 0.27
Key: AAA abdominal aortic aneurysm, CIA common iliac artery, TIA transient ischemic attack
*Presented as mean and SD
**Previous cardiac surgery, myocardial infarction or disabling angina pectoris
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bleeding (n = 11), thrombosis (n = 12), pseudoaneurysm
(n = 4), stenosis (n = 1). Access-related re-intervention
procedures were suture of bleedings (n = 11), distal em-
bolectomies (n = 11), patch angioplasties (n = 5), and
thromboendarterectomy of the common femoral artery
(n = 1). There were two early deaths in patients with
access-related re-interventions, both of whom were
treated for rupture at primary EVAR. Both of these re-
interventions were done on day 1 after EVAR, and the
patients died on days 3 and 7.
Non-access-related re-interventions
Incidence
The median time between EVAR and the first non-
access-related re-intervention was 14 months (range 0–
91) (Fig. 2). Eleven patients (3 %) had two non-access-
related re-interventions, 4 patients (1 %) had three, and
one patient (0.2 %) had four. The overall incidence of
non-access-related re-intervention was 7 per 100 patient
years with the highest incidence (12/100 patient years)
during the first year after primary EVAR (Fig. 3). The
number of patients with re-interventions were 60/379
(16 %) for atherosclerotic aneurysms, 3/12 (25 %) for
inflammatory aneurysms, 2/13 (15 %) for mycotic aneu-
rysms and 0/1 (0 %) for others (iliac aneurysm in
previous dissection).
Indications
Fifty-one (60 %) of the non-access-related re-interventions
were initiated from findings on follow-up imaging and 34
(40 %) from symptoms. Presenting symptoms were new
onset of leg pain or claudication caused by iliac limb
thrombosis (n = 12) or stenosis (n = 1), fever, abdominal
pain or sepsis caused by graft infection (n = 7 in 5 pa-
tients), abdominal pain and shock due to rupture (n = 4),
abdominal compartment syndrome after rupture at pri-
mary repair (n = 3), abdominal pain due to bowel ischemia
(n = 2), abdominal or back pain caused by aneurysm
expansion (n = 2), continued bleeding after RAA (n = 2)
and notable aneurysm expansion by patient (n = 1). The
most common indications for non-access-related re-
intervention were endoleak type I (n = 19), type II (n = 21),
or type III (n = 5); stent graft migration (n = 9); and graft
limb thrombosis (n = 14 in eleven patients). Six of the
patients with thrombosis had an iliac landing zone in the
external iliac artery. The frequency of graft limb throm-
bosis was 6.1 % if the landing zone was the external iliac
artery compared to 0.7 % if the landing zone was in the
common iliac artery (p < 0.001). Aneurysm expansion was
present in 39 % of the non-access-related re-interventions
(Fig. 3 and Table 2). Four patients had secondary rupture
after EVAR as the indication for re-intervention; details
are given in Table 2.
Fig. 1 Freedom from non-access related re-intervention presented in months after primary EVAR, comparing patients treated for rupture vs
non-ruptured aneurysms. Cumulative re-intervention free survival two years after primary repair was 80 % for patients treated for rupture and
89 % for patients treated for non-ruptured AAA. A standard error of 10 % was reached after 3.4 years in the patient with ruptured aneurysms
and after >9 years in the non-ruptured patients
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Separate analysis of the time to re-intervention was
done for all types of re-interventions with >5 procedures
for each group. Embolization of endoleaks and additional
iliac stent grafts were performed significantly later after
primary EVAR compared to thrombolysis and distal bare
metal stent (p = 0.05) and there was also a tendency in the
same direction between embolization and additional iliac
stent graft compared to proximal extensions (p = 0.06),
(Table 3).
Procedures
The non-access-related re-interventions were endovas-
cular, in 69 of 85 cases (81 %), open in 15/85 (18 %), and
a hybrid procedure with both endovascular and open
technique in one case (1 %). Since a combination of dif-
ferent procedures was performed at the same re-
intervention episode in nine patients (in eight cases two
different procedures and in one case a combination of
three different procedures) the total number of re-
intervention procedures was 95 (Table 3).
Embolizations
The most frequent non-access-related re-intervention
procedure was embolization of endoleaks (21 procedures
in 17 patients). One patient underwent three embolization
episodes and two patients two episodes. Embolization was
performed with coils in 8 procedures, with both coils and
a transcatheter liquid embolization agent (ethylene vinyl
alcohol copolymer, Onyx®, Covidien, Mansfield, MA,
USA) in 4 procedures, and with Onyx® alone in 9 proce-
dures. Indications were persistent type-II endoleak with
sac expansion in 18 procedures. Reasons for re-
intervention in the three patients without sac expansion
were postoperative retroperitoneal bleeding from the
aneurysm fed by type-II endoleak in one patient with sec-
ondary infected aneurysm, type II endoleak with massive
outflow through an aorto-caval fistula in one patient, and
Fig. 2 Survival after EVAR comparing patients with and without re-interventions. Cumulative survival at 5 years was 72 % for patients with
re-interventions and 59 % for patients without re-interventions. A standard error of 10 % was reached after 7.5 years in the patient with
re-interventions and after >9 years in patients without re-interventions
Fig. 3 Annual incidence of non-access-related re-interventions after
primary EVAR
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treatment of type II endoleak without sac expansion in
one patient with preoperative suspicion of type I endoleak.
Embolization procedures were done through arterial
puncture in the groin, except in one case with direct per-
cutaneous sac puncture. Target vessels were lumbar arter-
ies in 11 procedures, inferior mesenteric artery in three,
both lumbar arteries and inferior mesenteric artery in five,
and the aneurysm sac in two cases.
Additional iliac stent grafting
Placement of an additional iliac stent graft was the sec-
ond most common non-access-related re-intervention
procedure (n = 19). In most cases, the additional stent
graft extended the distal seal further down into the iliac
vessels (n = 16) and in three cases it secured the overlap
between the main bifurcated graft and the initial iliac
stent graft. The additional iliac stent grafts extending the
Table 2 Rupture as indication for re-intervention. Details of primary EVAR, outcome and follow up
Primary EVAR Time to reinterven-tion (days) Re-intervention Survival Follow up (days)
Patient 1 Non-rupture 84 Proximal cuff Dead 16
Bifurcated Infected EVAR –Chimney graft to renal arteries
Patient 2 Non-rupture 166 Proximal Dead 3
Bifurcated Extension- Cuff
Patient 3 Rupture 2 Bifurcated EVAR in previous tube graft Alive 276
Tube graft
Patient 4 Non-rupture 1875 Distal extension Alive 32
Bifurcated
Table 3 Number of re-intervention procedures performed for each group of re-interventions. Number of patients, days after primary











ENDOVASCULAR Embolisation 21 17 1029 (578–1357)a 20 1
Additional iliac stent graft 19 17 821 (539–1414)a 15 4
Proximal extension 12 12 239(68–1163)a 6 6
Thrombolysis 8 7 41 (18–90)a 0 8
Iliac bare metal stent 6 6 27 (8–242)a 3 3
Relining 5 5 0; 40; 44; 415; 2151b 4 1
Drainage of aneurysm sac in infected aneurysm 1 1 773b 0 1
Bifurcated stent graft in previous isolated
iliac stent graft/aortic tube graft
2 2 2; 7b 1 1
Renal artery stent 1 1 581b 1 0
Palmaz stent 1 1 105b 1 0
Balloon dilatation of iliac limb stent graft 1 1 77b 0 1
Stent graft external to internal iliac artery
in combination with femoro-femoral bypass
1 1 13b 1 0
Onyx in proximal sealing zone due to endoleak type I 1 1 202b 1 0
OPEN SURGERY Open surgery with stent graft extirpationc 4 4 641; 785; 1069; 1420b 2 2
Femoro-femoral crossover bypass 4 4 0; 13; 20; 80b 1 3
Laparotomy due to abdominal compartment syndrome 3 3 0; 1; 20b 0 3
Bowel resection 2 2 5; 32b 0 2
Rafi of small intestine in patient with
aortoenteric fistula. (Two operations on one patient
with mycotic AAA and gastrointestinal fistula)
2 2 19; 20b 0 2
Laparotomy with lumbar artery ligature 1 1 2160b 1 0
aDays after primary EVAR presented as median and interquartile range
bPresented as days after primary EVAR for each procedure
cOpen surgery with stent graft extirpation was performed with axillobifemoral reconstruction in three cases and abdominal tube graft in one case
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distal seal landed in the common iliac artery in 9
patients and in the external iliac artery in 7 patients. In-
dications for additional iliac stent grafts were insufficient
distal sealing length (n = 10), visible endoleaks of type Ib
(n = 7), or visible endoleaks of type III (n = 3). Fourteen
of the 19 re-interventions were done more than two
years after the primary procedure, and in one patient a
distal extension sealed an aneurysm rupture 5 years after
EVAR.
Proximal extension
Proximal cuff extension was performed in 12 patients
during follow-up. Seven of these were treated during the
first year of follow-up for endoleak of type 1a. Three of
five patients requiring proximal extension more than
one year after the index procedure were initially treated
with stent grafts without anchoring barbs.
Stent graft relining
Stent graft relining was done in five patients, with a
different indication for each one. The indications were:
type-IV endoleak, limb occlusion, conversion to aortou-
niiliac graft due to endoleak type I, graft stenosis, and
damage to the stent graft at open operation in a patient
with mycotic AAA.
Open surgery
Three axillobifemoral bypasses with removal of an
infected stent graft were done 21, 26, and 35 months
after EVAR. Two were secondary infections and one
was a primary mycotic AAA, diagnosed before treat-
ment. One patient with secondary infection died
6 days after surgery and the other two were alive
after 5 and 7 years of follow-up. Four femoro-femoral
bypasses were done 0, 13, 20, and 80 days after
EVAR. Three were due to thrombosis of an iliac limb
and one was an adjunct procedure to exclude an
endoleak of type Ib with an aorto-uni-iliac converter.
A late conversion to open repair (after 4 years) and
an open lumbar artery ligation (after 6 years) were
done in two patients for persistent type-II endoleaks
with aneurysm expansion. Both patients were alive
after another 2 and 4 years of follow-up. Two pa-
tients had bowel resection due to post-EVAR mesen-
teric ischemia. At the primary procedure both
patients had bilateral occlusion of the internal iliac
arteries. One of the patients was operated with an
iliac-branched graft to the internal iliac artery at pri-
mary repair but the graft occluded day 2 after sur-
gery. The second patient had staged embolization of
the internal iliac artery 25 days before primary repair.
Factors associated with non-access-related
re-interventions
In univariate testing, male gender (p = 0.046), aneurysm
size at primary repair (p = 0.026), and ruptured
aneurysm at primary repair (p = 0.002) were associated
with non-access-related re-interventions (Table 1). In
the multivariate model, rupture (hazard ratio (HR) =
2.23, 95 % confidence interval (CI) 1.13–4.40; p = 0.020)
and male gender (HR = 2.97, CI 1.07–8.20; p = 0.036)
remained statistically significant.
Outcome
Thirty-day mortality after non-access-related re-
interventions was 6.2 % (4/65 patients). There were four
early deaths, all occurred in patients with re-
interventions due to symptoms, 4/27 (15 %) and none in
patients with re-intervention due to surveillance imaging
0/38 (p = 0.014). Cumulative survival at five years was
72 % in patients with re-intervention and 59 % in
patients without re-intervention (p = 0.21) (Fig. 2). Sur-
vival was not significantly different between different
aneurysm pathologies (p = 0.37) or types of stent grafts
(p = 0.86). Cumulative re-intervention-free survival at
two years was 81 % in patients treated for rupture and
90 % in patients treated for unruptured aneurysms (p =
0.002) (Fig. 1).
Discussion
The main finding of the present study was that non-
access-related re-intervention rates remain considerable
after EVAR. Outcomes after re-interventions were gener-
ally good, except when they were initiated by rupture or
infection.
Re-interventions and late complications are the Achil-
les heel of EVAR. While there is a relative consensus on
indications for re-intervention, little is reported on their
incidence and actual clinical outcomes. Stent graft devel-
opment in recent years has focused on lower-profile and
easier deployment rather than on increased long-term
durability. One of the main challenges in EVAR develop-
ment are the endoleak-related re-interventions per-
formed to maintain the integrity of the stent graft. Not
only reporting re-intervention rates but also achieving a
better understanding of the various entities of re-
interventions and late complications after EVAR may
improve future stent graft designs and clinical follow-up
programs. In this study, we followed a cohort of 405
consecutive patients treated with standard EVAR and ana-
lyzed all access- and non-access-related re-interventions.
Access related re-interventions
The access related re-interventions came early after pri-
mary repair and had little or no influence on the long-
term results. The increased incidence of re-interventions
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after access closure with open cut down was most likely
due to the patient selection since open cut down was
used only in patients with heavy calcification of the fem-
oral arteries.
Non-access related re-interventions
The main focus of this report is on non-access related
re-interventions and further analysis is hereafter focused
on this subject. Some of our results were as expected.
The total prevalence of 16 % and the rate of 7 % per 100
patient years are in line with most other reports [16–19].
Most re-interventions were performed with endovascu-
lar technique, and were initiated by follow-up imaging.
Indications were dominated by type-I and type-II endo-
leaks. Hospital stay was short for these patients, morbid-
ity low, and survival good. Furthermore, we found that
patients treated for rupture had a higher re-intervention
rate than patients treated for intact AAA. As expected,
there was a more dismal prognosis when re-intervention
was caused by symptoms. There were four secondary
ruptures (4/405, 1 %), both the incidence and the fact
that the majority of these occurred late after primary re-
pair also corresponds well with previous reports [20].
Furthermore, our findings that stent graft limb occlu-
sions occurred early after primary repair and that most
re-interventions can be performed with endovascular
technique are consistent with previous reports [16].
Some of our findings were more difficult to predict.
Women had significantly fewer re-interventions then
men (7 vs. 18 %). Possible explanations include smaller
sizes of aneurysms, necks and iliac arteries in women,
but also one may also speculate that a more restrictive
attitude to reinterventions in women among patients
and physicians may play a role. This has not been ob-
served earlier [16, 21] and may well be an effect of insuf-
ficient statistical power, due to the limited number of
women in our series. Previous reports have shown re-
duced overall survival in women [16, 22], which we
could not confirm although there was a trend in the
same direction. Cumulative survival at five years was
49 % for women and 65 % for men (p = 0.18).
Median time to the first non-access-related re-
intervention was relatively long: 14 months. This finding
has possible clinical implications, since follow-up
schemes are usually most intense during the first post-
operative year. Interestingly, certain re-intervention pro-
cedures were more frequent early in the follow-up
period and others later. For instance, 7 of 12 proximal
extensions were done during the first postoperative year
while 14 of 19 additional iliac stent grafts were placed
more than two years after the index procedure. Place-
ment of an additional iliac stent graft was the second
most common re-intervention procedure. The high fre-
quency and tardy occurrence of this re-intervention
suggests that it may in fact be a more important cause
of late EVAR failure than has hitherto been recognized.
Indeed, one of two late ruptures in our cohort was
caused by distal stent graft migration. The importance of
iliac seal for long-term stability after EVAR has also been
pointed out by Ohrlander et al. They found that a
greater diameter of the common iliac arteries was asso-
ciated with an increased re-intervention rate [23]. It has
also been shown that iliac diameter increases over time
in patients treated with EVAR [24]. In an experimental
study, our group showed that increased iliac angulation
is a determining factor in the genesis of extraction forces
induced on iliac limb stent grafts [25]. An increased
focus on iliac landing zone and fixation may help to im-
prove long-term durability after EVAR.
We discerned some trends that were not statistically
significant in our series, including a tendency of improved
5-year survival in patients requiring a re-intervention
compared to those who did not. This trend contrasts with
a recent multicenter series from 17 centres, which did find
a significant increase in aneurysm-related mortality in pa-
tients who had undergone re-interventions [16]. However,
the finding in our series was based on all-cause mortality,
not aneurysm-related mortality, which may at least partly
explain the difference [16].
The present study had both strengths and limitations.
The limitations included the ones that are inherent in a
retrospective observational study, e.g., selection bias and
the importance of non-registered confounders. Further-
more median follow-up was only 29 months. Another
limitation was the single-centre design, as the patient
numbers may have been insufficient for detection and
validation of more rare events. A single-centre design
also has certain advantages, since it allows registration
of more detailed information. Another obvious strength
was the almost complete follow-up.
Conclusions
Non-access-related re-interventions rates after infrarenal
EVAR is still considerable and more so when primary
EVAR was performed due to ruptured aneurysms. Endo-
leak embolizations and additional iliac limb stent grafts
were the most common and performed later after
primary repair compared to other re-interventions. Most
were done during short-stay admissions with minimally
invasive techniques, and prognosis was generally good, ex-
cept when the re-intervention was caused by aneurysm
rupture or stent graft infection.
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